Metraipolis › archive › dc_fa97953abfd9

Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review — Europe PMC PMID:42524108

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42524108
DOI
10.3389/fonc.2026.1823066
License (as archived)
solo-consultazione
Archived
2026-10-18T07:16:32.276Z
SHA-256 of the archived text
96d56c8c23c6138bddab4b3f6a5dde4581dece6533e245d55b63ef688dd7d5c8
Stable URL of this page
https://metraipolis.com/documento/dc_fa97953abfd9

How to cite

Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review — Europe PMC PMID:42524108 — Europe PMC (en), https://europepmc.org/article/MED/42524108 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fa97953abfd9 (Metraipolis archive dc_fa97953abfd9, sha256 96d56c8c23c6138bddab4b3f6a5dde4581dece6533e245d55b63ef688dd7d5c8)
BibTeX
@misc{dcfa97953abfd9,
  title = {Venetoclax combined with azacitidine in the treatment of secondary myelodysplastic syndrome following multiple myeloma: a case report and literature review — Europe PMC PMID:42524108},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42524108},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fa97953abfd9; sha256 96d56c8c23c6138bddab4b3f6a5dde4581dece6533e245d55b63ef688dd7d5c8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42524108. Agents can read the archived copy with the MCP tool read_document.